Asia Pacific Pharmacy Automation Market

Asia Pacific Pharmacy Automation Market by Product (Automated Medication Dispensing & Storage Systems, Automated Table-Top Counters, Medication Compounding), End User (Inpatient Pharmacies, Outpatient Pharmacies, Retail Pharmacies) - Forecast to 2027

Report Code: MD 8123 Jun, 2022, by marketsandmarkets.com

[184 Pages Report] The Asia Pacific pharmacy automation market is projected to reach USD 725 million by 2027 from USD 453 million in 2022, at a CAGR of 9.8% during the forecast period. Growth in the market is mainly driven by the growing investments for healthcare infrastructure development and the rising geriatric population leading to increased adoption of automated dispensing systems. Moreover, pharmacy automation companies are seeking new opportunities by expanding their presence across emerging markets. However, the high costs of implementing pharmacy automation systems and stringent regulations that delay product launches can inhibit the growth of this market.

Asia Pacific Pharmacy Automation Market

To know about the assumptions considered for the study, Request for Free Sample Report

COVID-19 Impact

According to our findings, the Asia Pacific pharmacy automation market is expected to grow at an approximate CAGR of 9.5-10.0% during the next two years. According to our analysis, the below factors are playing a key role in shaping the growth of the Asia Pacific market;

  • Due to the COVID-19 outbreak, the pharmaceutical industry registered significant growth in 2020 and 2021, but the industry’s entire supply chain, from raw materials to manufacturing and delivery, was severely impacted.
  • The high infection rate of COVID-19 led to an increased demand for medication and drug dispensing in hospitals. The pandemic increased the demand for medications to provide life-saving support to critically ill COVID-positive patients. Approximately 15% of COVID-positive patients required hospitalization and needed constant dispensing of drugs from pharmacies.
  • The shift in demand towards automated systems forced key players to strategize their manufacturing capabilities, focus on new product development, and seek out optimum supply chain strategies for COVID-19 essentials.

Asia Pacific Pharmacy Automation Market Dynamics

Driver:  Growing need to minimize medication errors

The recognized leading causes of hospital readmission are medication errors and dispensing errors. Poor order communication between physicians and pharmacists, dangerous storage practices in pharmacies, and the confusion arising from similar labels and drug prescriptions during the preparation or dispensing of drugs or during drug administration are some key factors contributing to medication errors. Automated systems are considered one of the most efficient solutions to minimize these errors. In the past, the successful implementation of automated dispensing cabinets (ADCs) and automated dispensing machines (ADMs) in hospitals led to significant reductions in the number of dispensing and medication errors in hospitals.

Restraint: Reluctance to adopt pharmacy automation systems

Despite their benefits, several healthcare professionals and providers are reluctant to adopt or accept IT-based approaches to pharmacy management. This is particularly evident when cultural barriers are involved, especially in emerging economies. Therefore, many pharmacists do not want assistance and are reluctant to adopt pharmacy automation systems as part of their dispensing regimen. Although the benefits of automated pharmacy systems are considerable and the extensive adoption of technology verifies this, until now, only large-volume pharmacies and hospitals could justify the returns on investment (ROIs) obtained from installing these automated systems.

Opportunity: High growth opportunities in emerging markets

Emerging economies such as China, India, and South Korea are expected to become a focal point for growth in the Asia Pacific pharmacy automation market. This can primarily be attributed to the rising geriatric population and the growing incidence of chronic disorders in Asia Pacific countries. This is expected to encourage market players to invest in this region in the coming years. Developing countries have large geriatric populations. According to the UN report on World Population Ageing (2019), East and Southeast Asia will register the highest increase in the number of geriatric individuals, with the population aged 65 years or over projected to increase from 260.6 million in 2019 to nearly 572.5 million by 2050. This increasing geriatric population will lead to an increase in the number of prescriptions dispensed, which, in turn, will increase the demand for pharmacy automation systems. Moreover, with the rapid economic growth in several Asian countries, the need for pharmaceutical products and services is expected to increase in their respective healthcare systems. This, coupled with the growing awareness about medication errors and rising focus on the effective management of workloads at pharmacies through the implementation of automated systems, is expected to create potential growth opportunities for players operating in the Asia Pacific pharmacy automation market.

Challenge: Stringent regulatory procedures

The stringency of regulatory approvals depends on the class to which a particular device belongs; it may vary from one region to another. Several state boards of pharmacies (agencies of a state responsible for the control and regulation of the practice of a pharmacy and the licensing of pharmacists in the state) have different requirements for using automated dispensing devices (ADDs) in healthcare practices. Thus, manufacturers of automated systems for pharmacies have to adhere to various regulations; ensuring such compliance is a tedious task and can delay product launches.

The pharmacy packaging and labeling system segment is expected to have the highest CAGR during the forecast period

Based on products, the Asia Pacific pharmacy automation market is segmented into automated medication dispensing and storage systems, automated packaging and labeling systems, automated tabletop counters, automated medication compounding systems, and other pharmacy automation systems. The pharmacy packaging and labeling system segment is expected to register the highest growth during the forecast period. This is mainly due to the need to improve dispensing accuracy & productivity and lower the overall cost of the process by helping its users avoid such confusions by providing all medications with clear labels and distinct appearances.

Centralized pharmacies segment accounted for the largest share of the automated medication dispensing and storage systems market in 2021

Based on applications/operations, the automated medication dispensing and storage systems market is segmented into centralized and decentralized pharmacies. Centralized pharmacies accounted for the largest share of the Asia Pacific automated medication dispensing and storage systems market in 2021. This can be attributed to the high adoption of centralized models for end-to-end medication dispensing in hospitals, pharmacies, and nursing units.

The inpatient pharmacies segment accounted for the largest share of Asia Pacific pharmacy automation market in 2021

Based on end users, the Asia Pacific pharmacy automation market is segmented into inpatient pharmacies, outpatient pharmacies, retail pharmacies, and pharmacy benefit management organizations and mail-order pharmacies. In 2021, inpatient pharmacies accounted for the largest share of this market. This is mainly due to the advantage of faster dispensing of medications within hospital facilities as compared to the traditional manual methods.

China is expected to register the highest CAGR during the forecast period

China is expected to register the highest growth during the forecast period. This can be attributed to the increasing initiatives to improve the country’s healthcare infrastructure and the rising geriatric population in China.

Asia Pacific Pharmacy Automation Market by Trend

To know about the assumptions considered for the study, download the pdf brochure

Key Market Players

The prominent players in the Asia Pacific pharmacy automation market include Becton, Dickinson and Company (US), Yuyama Co., Ltd/Yuyama Mfg Co., Ltd (Japan), Omnicell, Inc. (US), KUKA AG (Swisslog Healthcare) (Germany), TOSHO Co, Inc. (Japan), Cerner Corporation (US), TouchPoint Medical Solutions (US), Takazono Corporation (Japan), Capsa Healthcare (US), and ARxIUM, Inc. (US).

Get online access to the report on the World's First Market Intelligence Cloud

  • Easy to Download Historical Data & Forecast Numbers
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
Request Sample

Scope of the Report

Report Metric

Details

Market size available for years

2020–2027

Base year considered

2021

Forecast period

2022–2027

Forecast units

Value (USD Million)

Segments covered

Product and End user

Countries covered

Australia, Japan, China, India, South Korea, Singapore, Thailand, and Rest of Asia Pacific (RoAPAC)

Companies covered

Becton, Dickinson and Company (US), Yuyama Co., Ltd/Yuyama Mfg Co., Ltd (Japan), Omnicell, Inc. (US), KUKA AG (Swisslog Healthcare) (Germany), TOSHO Co, Inc. (Japan), Cerner Corporation (US), TouchPoint Medical Solutions (US), Takazono Corporation (Japan), Capsa Healthcare (US), ARxIUM, Inc. (US), ScriptPro LLC (US), Tension Corporation (US), Meditech Pharmacy Management Solutions (Belgium), Willach Group (Germany), and Stäubli International (Switzerland)

The study categorizes the Asia Pacific pharmacy automation market based on product, end user and regional level.

Asia Pacific Pharmacy Automation Market, By Product

  • Automated Medication Dispensing and Storage Systems
    • Automated Medication Dispensing and Storage Systems, by Type
      • Robots/Robotic Automated Dispensing Systems
      • Carousels
      • Automated Dispensing Cabinets
    • Automated Medication Dispensing and Storage Systems, By Application/Operation
      • Centralized Pharmacies
      • Decentralized Pharmacies
  • Automated Packaging and Labelling Systems
  • Automated Tabletop Counters
  • Automated Medication Compounding Systems
  • Other Pharmacy Automation Systems

Asia Pacific Pharmacy Automation Market, By End User

  • Inpatient Pharmacies
    • Acute Care Systems
    • Long Term Care Facilities
  • Outpatient Pharmacies
    • Outpatient/Fast-Track Clinics
    • Hospital Retail Settings
  • Retail Pharmacies
  • Pharmacy Benefit Management Organizations and Mail-Order Pharmacies

Asia Pacific Pharmacy Automation Market, by Country

  • Australia
  • Japan
  • China
  • India
  • South Korea
  • Singapore
  • Thailand
  • Rest of Asia Pacific (RoAPAC)

Recent Developments

  • In 2022, Capsa Healthcare (US) announced the acquisition of Humanscale Healthcare (US), a designer and manufacturer of flexible technology solutions and computing workstations based in New York. Combined, Capsa now offers the broadest product suite in the market and expands its ability to provide ergonomically tailored point-of-care computing solutions to healthcare partners worldwide.
  • In 2021, Omnicell, Inc. (US) opened a new software development center in Bangalore, India, that will focus on product innovations to deliver cloud-based infrastructures.
  • In 2020, Capsa Healthcare (US) acquired RoboPharma, which delivers customized high-speed prescription filling solutions for community pharmacies, hospitals, wholesalers, and central fill operations. With the acquisition, Capsa broadened its reach in the European and Asian pharmacy automation markets.
  • In 2020, KUKA AG (Swisslog Healthcare) (Germany) launched its innovative Open Pharmacy platform to enable the transformation of pharmacies into health hubs. The platform includes AirTec, a fast transport solution natively connected to a new generation of EvoTec and TwinTech smart storage solutions. Additionally, the platform includes Living Shelves, a digital kiosk, and MedyBox, a 24/7 secure dispenser.
  • In 2019, Capsa Healthcare (US) launched Kirby Lester KL-SR, a robotic dispenser for busy retail and hospital outpatient pharmacies. The KL-SR is a vial-filling robot.

Frequently Asked Questions (FAQ):

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

TABLE OF CONTENTS

1 INTRODUCTION (Page No. - 25)
    1.1 OBJECTIVES OF THE STUDY
    1.2 MARKET DEFINITION & SCOPE
           1.2.1 INCLUSIONS & EXCLUSIONS
           1.2.2 MARKET SEGMENTATION
                    FIGURE 1 ASIA PACIFIC PHARMACY AUTOMATION MARKET SEGMENTATION
           1.2.3 YEARS CONSIDERED
    1.3 CURRENCY
           TABLE 1 EXCHANGE RATES FOR CONVERSION TO USD
    1.4 STAKEHOLDERS

2 RESEARCH METHODOLOGY (Page No. - 29)
    2.1 RESEARCH APPROACH
    2.2 RESEARCH METHODOLOGY DESIGN
           2.2.1 SECONDARY RESEARCH
                    2.2.1.1 Key data from secondary sources
           2.2.2 PRIMARY DATA
                    FIGURE 2 PRIMARY SOURCES
                    2.2.2.1 Key data from primary sources
                    2.2.2.2 Insights from primary experts
                               FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
                               FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND COUNTRY
    2.3 MARKET SIZE ESTIMATION
           FIGURE 5 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
           FIGURE 6 REVENUE SHARE ANALYSIS ILLUSTRATION
           FIGURE 7 TOP-DOWN APPROACH
           FIGURE 8 CAGR PROJECTIONS FROM THE ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
    2.4 DATA TRIANGULATION APPROACH
    2.5 MARKET SHARE ESTIMATION
    2.6 ASSUMPTIONS
    2.7 LIMITATIONS
           2.7.1 METHODOLOGY-RELATED LIMITATIONS
           2.7.2 SCOPE-RELATED LIMITATIONS
    2.8 RISK ASSESSMENT
           TABLE 2 RISK ASSESSMENT: ASIA PACIFIC PHARMACY AUTOMATION MARKET

3 EXECUTIVE SUMMARY (Page No. - 42)
    FIGURE 11 ASIA PACIFIC PHARMACY AUTOMATION MARKET, BY PRODUCT, 2022 VS. 2027 (USD MILLION)
    FIGURE 12 ASIA PACIFIC AUTOMATED MEDICATION DISPENSING & STORAGE SYSTEMS, BY TYPE, 2022 VS. 2027 (USD MILLION)
    FIGURE 13 ASIA PACIFIC AUTOMATED MEDICATION DISPENSING AND STORAGE SYSTEMS, BY APPLICATION/OPERATION, 2022 VS. 2027 (USD MILLION)
    FIGURE 14 ASIA PACIFIC PHARMACY AUTOMATION MARKET, BY END USER, 2022 VS. 2027 (USD MILLION)

4 PREMIUM INSIGHTS (Page No. - 45)
    4.1 ASIA PACIFIC PHARMACY AUTOMATION MARKET OVERVIEW
           FIGURE 15 GROWING NEED TO AUTOMATE WORKFLOWS AND REDUCE HEALTHCARE COSTS TO DRIVE MARKET GROWTH
    4.2 ASIA PACIFIC PHARMACY AUTOMATION MARKET, BY PRODUCT AND COUNTRY (2021)
           FIGURE 16 AUTOMATED MEDICATION DISPENSING AND STORAGE SYSTEMS TO DOMINATE THE ASIA PACIFIC MARKET IN 2021
    4.3 ASIA PACIFIC PHARMACY AUTOMATION MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
           FIGURE 17 CHINA IS EXPECTED TO REGISTER THE HIGHEST GROWTH RATE DURING THE FORECAST PERIOD
    4.4 ASIA PACIFIC PHARMACY AUTOMATION MARKET, BY COUNTRY (2020–2027)
           FIGURE 18 AUSTRALIA HELD THE LARGEST SHARE IN THE MARKET IN 2021

5 MARKET OVERVIEW (Page No. - 49)
    5.1 INTRODUCTION
    5.2 MARKET DYNAMICS
           FIGURE 19 ASIA PACIFIC PHARMACY AUTOMATION MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
           5.2.1 DRIVERS
                    5.2.1.1 Growing need to minimize medication errors
                    5.2.1.2 Decentralization of pharmacies
                    5.2.1.3 Rising geriatric population leading to increased adoption of automated dispensing systems
                               FIGURE 20 GLOBAL GERIATRIC POPULATION (65 YEARS & ABOVE), BY REGION
                    5.2.1.4 Growing investments for healthcare infrastructural development
                    5.2.1.5 Increasing specialty drug dispensing
                               TABLE 3 IMPACT ANALYSIS: MARKET DRIVERS
           5.2.2 RESTRAINTS
                    5.2.2.1 Reluctance to adopt pharmacy automation systems
                    5.2.2.2 High initial capital investments
                    5.2.2.3 Lack of skilled personnel
                               TABLE 4 IMPACT ANALYSIS: MARKET RESTRAINTS
           5.2.3 OPPORTUNITIES
                    5.2.3.1 Increasing awareness among pharmacists
                    5.2.3.2 High growth opportunities in emerging markets
                    5.2.3.3 Healthcare cost-reduction measures
                               TABLE 5 IMPACT ANALYSIS: MARKET OPPORTUNITIES
           5.2.4 CHALLENGES
                    5.2.4.1 Stringent regulatory procedures
                    5.2.4.2 Risk of cross-contamination
                               TABLE 6 IMPACT ANALYSIS: MARKET CHALLENGES
    5.3 INDUSTRY TRENDS
           5.3.1 CUSTOMIZABLE DRUG DISPENSING CABINETS
           5.3.2 PHARMACY ROBOTICS
           5.3.3 RADIOFREQUENCY IDENTIFICATION (RFID) IN PHARMACY AUTOMATION
                    TABLE 7 EXAMPLES OF RFID IN PHARMACY AUTOMATION SYSTEMS
           5.3.4 ELECTRONIC HEALTH RECORD INTEGRATION AND INTEROPERABILITY THROUGH PHARMACY AUTOMATION SYSTEMS
    5.4 KEY CONFERENCES & EVENTS
           TABLE 8 ASIA PACIFIC PHARMACY AUTOMATION MARKET: DETAILED LIST OF CONFERENCES & EVENTS
    5.5 PORTER’S FIVE FORCES ANALYSIS
           TABLE 9 PORTER’S FIVE FORCES ANALYSIS
           5.5.1 THREAT FROM NEW ENTRANTS
           5.5.2 THREAT FROM SUBSTITUTES
           5.5.3 BARGAINING POWER OF SUPPLIERS
           5.5.4 BARGAINING POWER OF BUYERS
           5.5.5 INTENSITY OF COMPETITIVE RIVALRY
    5.6 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
           TABLE 10 LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    5.7 REGULATORY ANALYSIS
           5.7.1 INDIA
           5.7.2 AUSTRALIA
           5.7.3 JAPAN
           5.7.4 CHINA
                    TABLE 11 CHINA: NMPA CLASSIFICATION OF MEDICAL DEVICES
    5.8 VALUE CHAIN ANALYSIS
           FIGURE 21 VALUE CHAIN: ASIA PACIFIC PHARMACY AUTOMATION MARKET
    5.9 TECHNOLOGY ANALYSIS
           TABLE 12 TECHNOLOGY AND INNOVATION IN THE ASIA PACIFIC PHARMACY AUTOMATION MARKET
    5.10 PATENT ANALYSIS
           5.10.1 PATENT PUBLICATION TRENDS FOR PHARMACY AUTOMATION SYSTEMS IN ASIA PACIFIC
           FIGURE 22 PATENT PUBLICATION TRENDS (2011–MAY 2022)
           5.10.2 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS
           FIGURE 23 TOP PATENT APPLICANTS & OWNERS (COMPANIES/INSTITUTIONS) FOR PHARMACY AUTOMATION SYSTEMS (JANUARY 2011–MAY 2022)
           FIGURE 24 TOP APPLICANTS IN ASIA PACIFIC FOR PHARMACY AUTOMATION SYSTEM PATENTS (JANUARY 2011–MAY 2022)
           TABLE 13 LIST OF PATENTS/PATENT APPLICATIONS IN THE ASIA PACIFIC PHARMACY AUTOMATION MARKET, 2021–2022
    5.11 ECOSYSTEM ANALYSIS
           FIGURE 25 ASIA PACIFIC PHARMACY AUTOMATION MARKET: ECOSYSTEM ANALYSIS
    5.12 IMPACT OF COVID-19 ON THE ASIA PACIFIC PHARMACY AUTOMATION MARKET

6 ASIA PACIFIC PHARMACY AUTOMATION MARKET, BY PRODUCT (Page No. - 73)
    6.1 INTRODUCTION
           TABLE 14 ASIA PACIFIC PHARMACY AUTOMATION MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
    6.2 AUTOMATED MEDICATION DISPENSING AND STORAGE SYSTEMS
           TABLE 15 POPULAR AUTOMATED MEDICATION DISPENSING SYSTEMS AVAILABLE IN THE MARKET
           TABLE 16 POPULAR AUTOMATED MEDICATION STORAGE SYSTEMS AVAILABLE IN THE MARKET
           TABLE 17 ASIA PACIFIC AUTOMATED MEDICATION DISPENSING AND STORAGE SYSTEMS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
           6.2.1 AUTOMATED MEDICATION DISPENSING AND STORAGE SYSTEMS, BY TYPE
                    TABLE 18 ASIA PACIFIC AUTOMATED MEDICATION DISPENSING AND STORAGE SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                    6.2.1.1 Robots/robotic automated dispensing systems
                               6.2.1.1.1 Growing need to curtail healthcare costs associated with medication errors will drive market growth
                                            TABLE 19 POPULAR ROBOTS/ROBOTIC AUTOMATED DISPENSING SYSTEMS AVAILABLE IN THE MARKET
                                            TABLE 20 ASIA PACIFIC ROBOTS/ROBOTIC AUTOMATED DISPENSING SYSTEMS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                    6.2.1.2 Carousels
                               6.2.1.2.1 Growing need to improve patient safety and automate pharmacy inventory workflows to support the demand for carousels
                                            TABLE 21 POPULAR CAROUSEL SYSTEMS AVAILABLE IN THE MARKET
                                            TABLE 22 ASIA PACIFIC CAROUSELS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                    6.2.1.3 Automated dispensing cabinets
                               6.2.1.3.1 Rising cases of medication errors to drive the demand for ADCs
                                            TABLE 23 POPULAR AUTOMATED DISPENSING CABINETS AVAILABLE IN THE MARKET
                                            TABLE 24 ASIA PACIFIC AUTOMATED DISPENSING CABINETS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
           6.2.2 AUTOMATED MEDICATION DISPENSING AND STORAGE SYSTEMS, BY APPLICATION/OPERATION
                    TABLE 25 ASIA PACIFIC AUTOMATED MEDICATION DISPENSING AND STORAGE SYSTEMS MARKET, BY APPLICATION/OPERATION, 2020–2027 (USD MILLION)
                    6.2.2.1 Centralized pharmacies
                               6.2.2.1.1 Rising demand for centralized pharmacies to optimize inventories, workflows, and patient safety to drive market
                                            TABLE 26 ASIA PACIFIC CENTRALIZED PHARMACIES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                    6.2.2.2 Decentralized pharmacies
                               6.2.2.2.1 Need for faster and more accurate medication dispensing to drive market growth
                                            TABLE 27 ASIA PACIFIC DECENTRALIZED PHARMACIES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
    6.3 AUTOMATED PACKAGING AND LABELING SYSTEMS
           6.3.1 NEED TO IMPROVE MEDICATION DISPENSING ACCURACY AND REDUCE THE COST ASSOCIATED WITH TIME AND LABOR TO DRIVE THE MARKET
                    TABLE 28 POPULAR AUTOMATED PACKAGING AND LABELING SYSTEMS CURRENTLY AVAILABLE IN THE MARKET
                    TABLE 29 ASIA PACIFIC AUTOMATED PACKAGING AND LABELING SYSTEMS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
    6.4 AUTOMATED TABLETOP COUNTERS
           6.4.1 INCREASING NUMBER OF PATIENT VISITS AND GROWING DEMAND FOR PRESCRIPTION MEDICATIONS PROPEL GROWTH IN THIS MARKET SEGMENT
                    TABLE 30 POPULAR AUTOMATED TABLETOP COUNTERS CURRENTLY AVAILABLE IN THE MARKET
                    TABLE 31 ASIA PACIFIC AUTOMATED TABLETOP COUNTERS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
    6.5 AUTOMATED MEDICATION COMPOUNDING SYSTEMS
           6.5.1 AUTOMATED MEDICATION COMPOUNDING SYSTEMS REDUCE THE COST PER DOSE OF MEDICATION AND THE NEED FOR MEDICATION OUTSOURCING
                    TABLE 32 POPULAR AUTOMATED COMPOUNDING SYSTEMS CURRENTLY AVAILABLE IN THE MARKET
                    TABLE 33 ASIA PACIFIC AUTOMATED MEDICATION COMPOUNDING SYSTEMS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
    6.6 OTHER PHARMACY AUTOMATION SYSTEMS
           TABLE 34 OTHER ASIA PACIFIC PHARMACY AUTOMATION SYSTEMS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)

7 ASIA PACIFIC PHARMACY AUTOMATION MARKET, BY END USER (Page No. - 89)
    7.1 INTRODUCTION
           TABLE 35 ASIA PACIFIC PHARMACY AUTOMATION MARKET, BY END USER, 2020–2027 (USD MILLION)
    7.2 INPATIENT PHARMACIES
           TABLE 36 PHARMACY AUTOMATION SOLUTIONS USED FOR HOSPITAL INPATIENT PHARMACIES
           TABLE 37 ASIA PACIFIC PHARMACY AUTOMATION MARKET FOR INPATIENT PHARMACIES, BY TYPE, 2020–2027 (USD MILLION)
           TABLE 38 ASIA PACIFIC PHARMACY AUTOMATION MARKET FOR INPATIENT PHARMACIES, BY COUNTRY, 2020–2027 (USD MILLION)
           7.2.1 ACUTE CARE SYSTEMS
                    7.2.1.1 Growing investments to improve acute care service quality to drive growth in this market
                               TABLE 39 ASIA PACIFIC PHARMACY AUTOMATION MARKET FOR ACUTE CARE SYSTEMS, BY COUNTRY, 2020–2027 (USD MILLION)
           7.2.2 LONG-TERM CARE FACILITIES
                    7.2.2.1 Increasing patient admissions in long-term care facilities to lead to higher demand for healthcare technology solutions
                               TABLE 40 PHARMACY AUTOMATION SOLUTIONS FOR LONG-TERM CARE FACILITIES
                               TABLE 41 ASIA PACIFIC PHARMACY AUTOMATION MARKET FOR LONG-TERM CARE FACILITIES, BY COUNTRY, 2020–2027 (USD MILLION)
    7.3 OUTPATIENT PHARMACIES
           TABLE 42 PHARMACY AUTOMATION SOLUTIONS USED IN OUTPATIENT PHARMACIES
           TABLE 43 ASIA PACIFIC PHARMACY AUTOMATION MARKET FOR OUTPATIENT PHARMACIES, BY TYPE, 2020–2027 (USD MILLION)
           TABLE 44 ASIA PACIFIC PHARMACY AUTOMATION MARKET FOR OUTPATIENT PHARMACIES, BY COUNTRY, 2020–2027 (USD MILLION)
           7.3.1 OUTPATIENT/FAST-TRACK CLINICS
                    7.3.1.1 Growing need to automate medication dispensing to reduce medication errors will support market growth
                               TABLE 45 ASIA PACIFIC PHARMACY AUTOMATION MARKET FOR OUTPATIENT/FAST-TRACK CLINICS, BY COUNTRY, 2020–2027 (USD MILLION)
           7.3.2 HOSPITAL RETAIL SETTINGS
                    7.3.2.1 Need for accurate medication dispensing and faster inventory management to drive market growth
                               TABLE 46 ASIA PACIFIC PHARMACY AUTOMATION MARKET FOR HOSPITAL RETAIL SETTINGS, BY COUNTRY, 2020–2027 (USD MILLION)
    7.4 RETAIL PHARMACIES
           7.4.1 GROWING NEED FOR PHARMACY AUTOMATION SYSTEMS TO ASSIST WITH FASTER PRESCRIPTION FILLING AND MEDICATION DISPENSING TO DRIVE MARKET GROWTH
                    TABLE 47 ASIA PACIFIC PHARMACY AUTOMATION MARKET FOR RETAIL PHARMACIES, BY COUNTRY, 2020–2027 (USD MILLION)
    7.5 PHARMACY BENEFIT MANAGEMENT ORGANIZATIONS AND MAIL-ORDER PHARMACIES
           7.5.1 NEED TO REDUCE LABOR COSTS ASSOCIATED WITH MEDICATION PACKAGING AND SUPPLY TO DRIVE MARKET GROWTH
                    TABLE 48 PHARMACY AUTOMATION SOLUTIONS USED IN MAIL-ORDER PHARMACIES
                    TABLE 49 ASIA PACIFIC PHARMACY AUTOMATION MARKET FOR PHARMACY BENEFIT MANAGEMENT ORGANIZATIONS AND MAIL-ORDER PHARMACIES, BY COUNTRY, 2020–2027 (USD MILLION)

8 ASIA PACIFIC PHARMACY AUTOMATION MARKET, BY COUNTRY (Page No. - 101)
    8.1 INTRODUCTION
           FIGURE 26 ASIA PACIFIC: PHARMACY AUTOMATION MARKET SNAPSHOT
           TABLE 50 ASIA PACIFIC PHARMACY AUTOMATION MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
    8.2 AUSTRALIA
           8.2.1 ADVANCED MEDICAL INFRASTRUCTURE AND INCREASING HEALTHCARE EXPENDITURE TO DRIVE MARKET GROWTH IN AUSTRALIA
                    TABLE 51 AUSTRALIA: KEY MACROINDICATORS
                    TABLE 52 AUSTRALIA: PHARMACY AUTOMATION MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
                    TABLE 53 AUSTRALIA: AUTOMATION MEDICATION DISPENSING AND STORAGE SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                    TABLE 54 AUSTRALIA: AUTOMATED MEDICATION DISPENSING AND STORAGE SYSTEMS MARKET, BY APPLICATION/OPERATION, 2020–2027 (USD MILLION)
                    TABLE 55 AUSTRALIA: PHARMACY AUTOMATION MARKET, BY END USER, 2020–2027 (USD MILLION)
                    TABLE 56 AUSTRALIA: PHARMACY AUTOMATION MARKET FOR INPATIENT PHARMACIES, BY TYPE, 2020–2027 (USD MILLION)
                    TABLE 57 AUSTRALIA: PHARMACY AUTOMATION MARKET FOR OUTPATIENT PHARMACIES, BY TYPE, 2020–2027 (USD MILLION)
    8.3 JAPAN
           8.3.1 LARGE GERIATRIC POPULATION IN THE COUNTRY DRIVES THE DEMAND FOR PHARMACY AUTOMATED SYSTEMS
                    TABLE 58 JAPAN: KEY MACROINDICATORS
                    TABLE 59 JAPAN: PHARMACY AUTOMATION MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
                    TABLE 60 JAPAN: AUTOMATION MEDICATION DISPENSING AND STORAGE SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                    TABLE 61 JAPAN: AUTOMATED MEDICATION DISPENSING AND STORAGE SYSTEMS MARKET, BY APPLICATION/OPERATION, 2020–2027 (USD MILLION)
                    TABLE 62 JAPAN: PHARMACY AUTOMATION MARKET, BY END USER, 2020–2027 (USD MILLION)
                    TABLE 63 JAPAN: PHARMACY AUTOMATION MARKET FOR INPATIENT PHARMACIES, BY TYPE, 2020–2027 (USD MILLION)
                    TABLE 64 JAPAN: PHARMACY AUTOMATION MARKET FOR OUTPATIENT PHARMACIES, BY TYPE, 2020–2027 (USD MILLION)
    8.4 CHINA
           8.4.1 GROWING INVESTMENTS IN HEALTHCARE INFRASTRUCTURE DEVELOPMENT IN CHINA TO SUPPORT THE GROWTH OF THE MARKET
                    TABLE 65 CHINA: KEY MACROINDICATORS
                    TABLE 66 CHINA: PHARMACY AUTOMATION MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
                    TABLE 67 CHINA: AUTOMATED MEDICATION DISPENSING AND STORAGE SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                    TABLE 68 CHINA: AUTOMATED MEDICATION DISPENSING AND STORAGE SYSTEMS MARKET, BY APPLICATION/OPERATION, 2020–2027 (USD MILLION)
                    TABLE 69 CHINA: PHARMACY AUTOMATION MARKET, BY END USER, 2020–2027 (USD MILLION)
                    TABLE 70 CHINA: PHARMACY AUTOMATION MARKET FOR INPATIENT PHARMACIES, BY TYPE, 2020–2027 (USD MILLION)
                    TABLE 71 CHINA: PHARMACY AUTOMATION MARKET FOR OUTPATIENT PHARMACIES, BY TYPE, 2020–2027 (USD MILLION)
    8.5 INDIA
           8.5.1 IMPROVING HEALTHCARE INFRASTRUCTURE WILL BOOST THE DEMAND FOR PHARMACY AUTOMATION SYSTEMS IN INDIA
                    TABLE 72 INDIA: KEY MACROINDICATORS
                    TABLE 73 INDIA: PHARMACY AUTOMATION MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
                    TABLE 74 INDIA: AUTOMATION MEDICATION DISPENSING AND STORAGE SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                    TABLE 75 INDIA: AUTOMATED MEDICATION DISPENSING AND STORAGE SYSTEMS MARKET, BY APPLICATION/OPERATION, 2020–2027 (USD MILLION)
                    TABLE 76 INDIA: PHARMACY AUTOMATION MARKET, BY END USER, 2020–2027 (USD MILLION)
                    TABLE 77 INDIA: PHARMACY AUTOMATION MARKET FOR INPATIENT PHARMACIES, BY TYPE, 2020–2027 (USD MILLION)
                    TABLE 78 INDIA: PHARMACY AUTOMATION MARKET FOR OUTPATIENT PHARMACIES, BY TYPE, 2020–2027 (USD MILLION)
    8.6 SOUTH KOREA
           8.6.1 RAPIDLY INCREASING GERIATRIC POPULATION AND INCREASING COVID-19 CASES WILL DRIVE MARKET GROWTH IN SOUTH KOREA
                    TABLE 79 SOUTH KOREA: KEY MACROINDICATORS
                    TABLE 80 SOUTH KOREA: PHARMACY AUTOMATION MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
                    TABLE 81 SOUTH KOREA: AUTOMATION MEDICATION DISPENSING AND STORAGE SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                    TABLE 82 SOUTH KOREA: AUTOMATED MEDICATION DISPENSING AND STORAGE SYSTEMS MARKET, BY APPLICATION/OPERATION, 2020–2027 (USD MILLION)
                    TABLE 83 SOUTH KOREA: PHARMACY AUTOMATION MARKET, BY END USER, 2020–2027 (USD MILLION)
                    TABLE 84 SOUTH KOREA: PHARMACY AUTOMATION MARKET FOR INPATIENT PHARMACIES, BY TYPE, 2020–2027 (USD MILLION)
                    TABLE 85 SOUTH KOREA: PHARMACY AUTOMATION MARKET FOR OUTPATIENT PHARMACIES, BY TYPE, 2020–2027 (USD MILLION)
    8.7 SINGAPORE
           8.7.1 IMPROVING HEALTHCARE INFRASTRUCTURE AND INCREASING ADOPTION OF AUTOMATED SYSTEMS TO SUPPORT MARKET GROWTH
                    TABLE 86 SINGAPORE: KEY MACROINDICATORS
                    TABLE 87 SINGAPORE: PHARMACY AUTOMATION MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
                    TABLE 88 SINGAPORE: AUTOMATION MEDICATION DISPENSING AND STORAGE SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                    TABLE 89 SINGAPORE: AUTOMATED MEDICATION DISPENSING AND STORAGE SYSTEMS MARKET, BY APPLICATION/OPERATION, 2020–2027 (USD MILLION)
                    TABLE 90 SINGAPORE: PHARMACY AUTOMATION MARKET, BY END USER, 2020–2027 (USD MILLION)
                    TABLE 91 SINGAPORE: PHARMACY AUTOMATION MARKET FOR INPATIENT PHARMACIES, BY TYPE, 2020–2027 (USD MILLION)
                    TABLE 92 SINGAPORE: PHARMACY AUTOMATION MARKET FOR OUTPATIENT PHARMACIES, BY TYPE, 2020–2027 (USD MILLION)
    8.8 THAILAND
           8.8.1 RISING ADOPTION OF AUTOMATED SYSTEMS IN THE HEALTHCARE SECTOR TO DRIVE MARKET GROWTH IN THAILAND
                    TABLE 93 THAILAND: KEY MACROINDICATORS
                    TABLE 94 THAILAND: PHARMACY AUTOMATION MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
                    TABLE 95 THAILAND: AUTOMATION MEDICATION DISPENSING AND STORAGE SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                    TABLE 96 THAILAND: AUTOMATED MEDICATION DISPENSING AND STORAGE SYSTEMS MARKET, BY APPLICATION/OPERATION, 2020–2027 (USD MILLION)
                    TABLE 97 THAILAND: PHARMACY AUTOMATION MARKET, BY END USER, 2020–2027 (USD MILLION)
                    TABLE 98 THAILAND: PHARMACY AUTOMATION MARKET FOR INPATIENT PHARMACIES, BY TYPE, 2020–2027 (USD MILLION)
                    TABLE 99 THAILAND: PHARMACY AUTOMATION MARKET FOR OUTPATIENT PHARMACIES, BY TYPE, 2020–2027 (USD MILLION)
    8.9 REST OF ASIA PACIFIC
           TABLE 100 REST OF ASIA PACIFIC: PHARMACY AUTOMATION MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
           TABLE 101 REST OF ASIA PACIFIC: AUTOMATED MEDICATION DISPENSING AND STORAGE SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
           TABLE 102 REST OF ASIA PACIFIC: AUTOMATED MEDICATION DISPENSING AND STORAGE SYSTEMS MARKET, BY APPLICATION/OPERATION, 2020–2027 (USD MILLION)
           TABLE 103 REST OF ASIA PACIFIC: PHARMACY AUTOMATION MARKET, BY END USER, 2020–2027 (USD MILLION)
           TABLE 104 REST OF ASIA PACIFIC: PHARMACY AUTOMATION MARKET FOR INPATIENT PHARMACIES, BY TYPE, 2020–2027 (USD MILLION)
           TABLE 105 REST OF ASIA PACIFIC: PHARMACY AUTOMATION MARKET FOR OUTPATIENT PHARMACIES, BY TYPE, 2020–2027 (USD MILLION)

9 COMPETITIVE LANDSCAPE (Page No. - 131)
    9.1 OVERVIEW
    9.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
           FIGURE 27 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN THE ASIA PACIFIC PHARMACY AUTOMATION MARKET
    9.3 KEY STAKEHOLDERS & BUYING CRITERIA
           9.3.1 KEY STAKEHOLDERS IN THE BUYING PROCESS
                    FIGURE 28 INFLUENCE OF STAKEHOLDERS IN THE BUYING PROCESS
                    TABLE 106 INFLUENCE OF STAKEHOLDERS IN THE BUYING PROCESS FOR THE TOP THREE PHARMACY AUTOMATION SYSTEMS
           9.3.2 BUYING CRITERIA
                    FIGURE 29 KEY BUYING CRITERIA FOR THE TOP THREE PHARMACY AUTOMATION SYSTEMS
                    TABLE 107 KEY BUYING CRITERIA FOR THE TOP THREE PHARMACY AUTOMATION SYSTEMS
    9.4 REVENUE SHARE ANALYSIS OF THE TOP MARKET PLAYERS
           FIGURE 30 REVENUE ANALYSIS OF KEY PLAYERS IN THE ASIA PACIFIC PHARMACY AUTOMATION MARKET
    9.5 MARKET SHARE ANALYSIS
           FIGURE 31 ASIA PACIFIC PHARMACY AUTOMATION MARKET SHARE, BY KEY PLAYER, 2021
           TABLE 108 ASIA PACIFIC PHARMACY AUTOMATION MARKET: DEGREE OF COMPETITION
    9.6 COMPETITIVE BENCHMARKING
           TABLE 109 ASIA PACIFIC PHARMACY AUTOMATION MARKET: DETAILED LIST OF PLAYERS
    9.7 COMPANY FOOTPRINT
           TABLE 110 FOOTPRINT OF COMPANIES IN THE ASIA PACIFIC PHARMACY AUTOMATION MARKET
           9.7.1 PRODUCT FOOTPRINT
                    TABLE 111 PRODUCT FOOTPRINT OF COMPANIES
           9.7.2 END-USER FOOTPRINT
                    TABLE 112 END-USER FOOTPRINT OF COMPANIES
    9.8 COMPANY EVALUATION QUADRANT
           9.8.1 STARS
           9.8.2 EMERGING LEADERS
           9.8.3 PERVASIVE PLAYERS
           9.8.4 PARTICIPANTS
                    FIGURE 32 ASIA PACIFIC PHARMACY AUTOMATION MARKET: COMPETITIVE LEADERSHIP MAPPING (2021)
    9.9 COMPETITIVE SCENARIO
           9.9.1 PRODUCT LAUNCHES/ENHANCEMENTS
                    TABLE 113 PRODUCT LAUNCHES/ENHANCEMENTS, 2019–2022
           9.9.2 DEALS
                    TABLE 114 DEALS, 2019–2022
           9.9.3 OTHER DEVELOPMENTS
                    TABLE 115 OTHER DEVELOPMENTS, 2019–2022

10 COMPANY PROFILES (Page No. - 146)
     10.1 KEY PLAYERS
(Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments)* 
             10.1.1 BECKTON, DICKINSON AND COMPANY
                        TABLE 116 BECTON, DICKINSON AND COMPANY: BUSINESS OVERVIEW
                        FIGURE 33 BECKTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2021)
             10.1.2 YUYAMA CO., LTD./YUYAMA MFG CO., LTD.
                        TABLE 117 YUYAMA CO., LTD./YUYAMA MFG CO., LTD.: BUSINESS OVERVIEW
             10.1.3 OMNICELL, INC.
                        TABLE 118 OMNICELL, INC.: BUSINESS OVERVIEW
                        FIGURE 34 OMNICELL, INC.: COMPANY SNAPSHOT (2021)
             10.1.4 KUKA AKTIENGESELLSCHAFT (SWISSLOG HEALTHCARE)
                        TABLE 119 KUKA AKTIENGESELLSCHAFT: BUSINESS OVERVIEW
                        FIGURE 35 KUKA AKTIENGESELLSCHAFT: COMPANY SNAPSHOT (2021)
             10.1.5 TOSHO CO, INC.
                        TABLE 120 TOSHO CO, INC.: BUSINESS OVERVIEW
             10.1.6 CERNER CORPORATION
                        TABLE 121 CERNER CORPORATION: BUSINESS OVERVIEW
                        FIGURE 36 CERNER CORPORATION: COMPANY SNAPSHOT (2021)
             10.1.7 TOUCHPOINT MEDICAL SOLUTIONS
                        TABLE 122 TOUCHPOINT MEDICAL: BUSINESS OVERVIEW
             10.1.8 TAKAZONO CORPORATION
                        TABLE 123 TAKAZONO CORPORATION: BUSINESS OVERVIEW
             10.1.9 CAPSA HEALTHCARE
                        TABLE 124 CAPSA HEALTHCARE: BUSINESS OVERVIEW
             10.1.10 ARXIUM, INC.
                        TABLE 125 ARXIUM: BUSINESS OVERVIEW
             10.1.11 SCRIPTPRO, LLC
                        TABLE 126 SCRIPTPRO, LLC: BUSINESS OVERVIEW
             10.1.12 TENSION CORPORATION
                        TABLE 127 TENSION CORPORATION: BUSINESS OVERVIEW
             10.1.13 MEDITECH PHARMACY MANAGEMENT SOLUTIONS
                        TABLE 128 MEDITECH PHARMACY MANAGEMENT SOLUTIONS: BUSINESS OVERVIEW
             10.1.14 WILLACH GROUP
                        TABLE 129 WILLACH GROUP: BUSINESS OVERVIEW
             10.1.15 STÄUBLI INTERNATIONAL: COMPANY OVERVIEW
                        TABLE 130 STÄUBLI INTERNATIONAL: BUSINESS OVERVIEW
*Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments might not be captured in case of unlisted companies. 

11 APPENDIX (Page No. - 176)
     11.1 INSIGHTS FROM INDUSTRY EXPERTS
     11.2 DISCUSSION GUIDE
     11.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
     11.4 AVAILABLE CUSTOMIZATIONS
     11.5 RELATED REPORTS
     11.6 AUTHOR DETAILS

This study involved the extensive use of both primary and secondary sources. The research process involved the study of various factors affecting the industry to identify the segmentation types, industry trends, key players, competitive landscape, key market dynamics, and key player strategies.

Secondary Research

This research study involved the use of comprehensive secondary sources; directories and databases such as D&B, Bloomberg Business, and Factiva; and white papers, annual reports, and company house documents. Secondary research was used to identify and collect information for this extensive, technical, market-oriented, and commercial study of the Asia Pacific pharmacy automation market. It was also used to obtain important information about the top players, market classification, and segmentation according to industry trends to the bottom-most level, country markets, technology perspectives, and key developments related to the market. A database of the key industry leaders was also prepared using secondary research.

Primary Research

In the primary research process, various sources from both the supply side and other participants were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include industry experts such as CEOs, presidents, vice presidents, directors, marketing directors, marketing managers, and related executives from various key companies and organizations in the pharmacy automation industry. The primary sources from the other participants group including hospital personnel, C-level executives, department heads, hospital directors, long-term care center personnel, and pharmacists. And others including, private consultants, contract manufacturers, suppliers, distributers and officials from Government regulatory bodies.

Asia Pacific Pharmacy Automation Market Size, and Share

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

The total size of the Asia Pacific pharmacy automation market was arrived at after data triangulation from different approaches, as mentioned below. After each approach, the weighted average of the approaches was taken based on the level of assumptions used in each approach.

Data Triangulation

After arriving at the market size, the total market was divided into several segments and subsegments. Data triangulation and market breakdown procedures were employed wherever applicable to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments. The following figure shows the market validation, source structure, and data triangulation methodology implemented in the market engineering process.

Objectives of the Study

  • To define, describe, segment, and forecast the Asia Pacific pharmacy automation market, by product, end user, and country
  • To provide detailed information about the factors influencing the market growth (such as drivers, restraints, opportunities, and challenges)
  • To analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall Asia Pacific pharmacy automation market
  • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
  • To estimate the market size and growth potential of the pharmacy automation market in the Asia Pacific region
  • To profile the key players in the Asia Pacific pharmacy automation market and comprehensively analyze their core competencies and market shares
  • To track and analyze competitive developments such as acquisitions, product launches, and expansions of the leading players in the Asia Pacific pharmacy automation market
  • To benchmark players within the Asia Pacific pharmacy automation market using the competitive leadership mapping framework, which analyzes market players on various parameters within the broad categories of business strategy, market share, and product offering
  • To evaluate and analyze the overall impact of COVID-19 on the Asia Pacific pharmacy automation market

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per your company’s specific needs. The following customization options are available for the report:

Product Analysis

  • Product matrix, which gives a detailed comparison of the product portfolio of each company

Company Information

  • Detailed analysis and profiling of additional market players (up to five)
Report Code
MD 8123
Published ON
Jun, 2022
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Asia Pacific Pharmacy Automation Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
CUSTOMIZED WORKSHOP REQUEST
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
©2023 MarketsandMarkets Research Private Ltd. All rights reserved
DMCA.com Protection Status Website Feedback